載入...
Hepatitis C: Treatment of difficult to treat patients
Over the past several years, more so recently, treatment options for hepatitis C virus (HCV) have seemed to exponentially grow. Up until recently, the regimen of pegylated interferon (peg-IFN) and ribavirin (RBV) stood as the standard of care. Direct acting antivirals, which target nonstructural pro...
Na minha lista:
| 發表在: | World J Hepatol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Baishideng Publishing Group Inc
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517154/ https://ncbi.nlm.nih.gov/pubmed/26244069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i15.1953 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|